Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities.
Market for our Common Stock
Our Common Stock is currently
approved for quotation on the OTC Pink Market under the symbol “DROR.” As soon as practicable, and assuming we satisfy all
necessary initial listing requirements, we intend to apply to have our Common Stock listed for trading on The Nasdaq Stock Market, although
we cannot be certain that any such application will be approved.
The following table sets forth
the high and low sale prices for our Common Stock for the periods indicated as reported by OTC. The high and low prices reflect inter-dealer
prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.
Quarter Ended
High
Low
December 31, 2023
$ 0.03
$ 0.0093
September 30, 2023
$ 0.0474
$ 0.01
June 30, 2023
$ 0.038
$ 0.0102
March 31, 2023
$ 0.04475
$ 0.0085
December 31, 2022
$ 0.0275
$ 0.009
September 30, 2022
$ 0.054
$ 0.0211
June 30, 2022
$ 0.074
$ 0.036
March 31, 2022
$ 0.1326
$ 0.035
December 31, 2021
$ 0.1349
$ 0.0811
September 30, 2021
$ 0.15
$ 0.0801
June 30, 2021
$ 0.34
$ 0.107
March 30, 2021
$ 0.58
$ 0.0475
Shareholders of Record
As
of March 29, 2024, there were 209 stockholders of record holding 495,454,546 shares of common stock.
Recent Sales of Unregistered Securities
During the fiscal year ended
December 31, 2023, all sales of equity securities not registered under the Securities Act were included in our Quarterly Reports on Form
10-Q and in our Current Reports on Form 8-K.
Repurchase of Equity Securities
We have no plans, programs
or other arrangements in regard to repurchases of our common stock.
43
Dividends
We have not paid any cash
dividends on shares of our Common Stock to date. It is the present intention of our board of directors to retain future earnings for the
development, operation, and expansion of its business, and our board of directors does not anticipate declaring or paying any cash dividends
for the foreseeable future. The payment of dividends is within the discretion of our board of directors and will be contingent upon our
future revenues and earnings, as well as its capital requirements and general financial condition, and we can give no assurances that
we will ever have excess funds available to pay dividends.
Securities Authorized for Issuance under Equity Compensation Plans
The table below sets forth
certain information as of December 31, 2023 regarding the shares of our Common Stock available for grant or granted under stock option
plans and other compensation arrangements that (i) were adopted by our stockholders and (ii) were not adopted by our stockholder.
Plan Category
Number of
securities to
be issued
upon exercise
of
outstanding
options,
warrants and
rights
Weighted
average
exercise price
of outstanding
options,
warrants, and
rights
Number of securities
remaining available for
future issuance under equity compensation plans
(excluding securities
reflected in common)
Equity Compensation plans approved by stockholders (1)
163,142,084
$ 0.0038480
245,692,304
Equity Compensation plans not approved by stockholders
—
—
—
Total
163,142,084
$ 0.0038480
245,692,304
(1) Represents shares approved for issuance under the 2021 Plan
and the 2023 Plan. All information in this table has been adjusted to give effect to the Share Exchange.
Use of Proceeds from the Sale of Registered Securities
None.
Item 6. [Reserved]
44